Located in Bridgeport, West Virginia, the United Hospital Center's Cecil B. Highland, Jr. & Barbara B. Highland Cancer Center, with its board-certified medical and radiation oncologists, offers patients access to the latest in cancer treatment. The center provides the entire continuum of cancer related services from prevention/early detection screening and education to surgery, medical and radiation oncology, inpatient and outpatient therapies, home care and, when appropriate, hospice services.
United Hospital Center's Cecil B. Highland, Jr. & Barbara B. Highland Cancer Center sponsors support groups for patients and families in conjunction with the American Cancer Society. In addition, community-wide cancer screenings and education programs are held throughout the year.
Along with standard cancer therapies provided throughout the U.S., the cancer center participates in clinical trials and is a member of the Southwest Oncology Group (SWOG) and National Surgical Breast & Bowel Project (NSABP), thus giving patients access to the latest in cancer treatment protocols and experimental chemotherapy not yet released by the Food and Drug Administration (FDA).
Specialized radiation treatments using the most up-to-date IMRT techniques, breast brachytherapy and prostate implants are also available as part of the center's services.
The United Hospital Center's Cecil B. Highland, Jr. & Barbara B. Highland Cancer Center is recognized by the American College of Surgeons Commission on Cancer as a Community Comprehensive Cancer Program.
The Cecil B. Highland, Jr. & Barbara B. Highland Cancer Center is a service of United Hospital Center. For more information on cancer services or upcoming screenings/educational programs, call (681) 342-1800, or click here to view our Annual Program Schedule or click here to view our Resouce Directory. For our annual report click here.
The following protocols are currently open for enrollment:
Please contact your physician or Judy Dye, RN, OCN, Oncology Program Coordinator at 681-342-1804 for more information.
For more information concerning institutional review board and clinical research click here.
Oncology Trials – Principal Investigator - Dr. Paul Brager
NSABP B43 A Phase III Clinical Trial comparing trastuzumab given concurrently with radiation therapy and radiation therapy alone for women with HER-2 positive DCIS resected by lumpectomy
NSABP B47 A Randomized Phase III Trial of adjuvant therapy comparing chemotherapy alone (six cycles of docetaxel plus cyclophosphamide or four cycles of docorubicin plus cyclophosphamide followed by weekly paclitaxel) to chemotherapy plus trastusumab in women with node positive or high risk node negative HER-2 low invasive breast cancer
NSABP P5 Statin polyp prevention trial in patients with resected colon cancer
CALGB 80702 A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX plus celecoxib or placebo for patients with resected stage III colon cancer
Cardiac Trial – Principal Investigator - Dr. Gerardo Lopez
Surgical Trial – Principal Investigator - Dr. Jeffrey Madden
Orthopaedic Trial – Principal Investigator - Dr. Gerald Farber